Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | METAP2 | P50579 | 1/20 | 0.48 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6351810 | 0.91 | KMT2A (0.52) | POLBALDH1A1KMT2ATSHRLMNA | |
| SCHEMBL6353699 | 0.87 | RAB9A (0.56) | ALDH1A1KMT2ATSHRLMNASMN1; SMN2 | |
| SCHEMBL6437241 | 0.85 | RPA1 (0.64) | ALDH1A1KMT2ALMNASMN1; SMN2MAPT | |
| SCHEMBL6353681 | 0.85 | KMT2A (0.64) | ALDH1A1KMT2ALMNASMN1; SMN2MAPT | |
| SCHEMBL6833237 | 0.81 | RAB9A (0.45) | POLBALDH1A1KMT2ATSHRLMNA | |
| SCHEMBL6833850 | 0.81 | RAB9A (0.45) | POLBALDH1A1KMT2ATSHRLMNA | |
| SCHEMBL6353696 | 0.79 | PTGES (0.56) | ALDH1A1KMT2ATSHRLMNASMN1; SMN2 | |
| SCHEMBL6830408 | 0.79 | SMN1; SMN2 (0.48) | KMT2ATSHRLMNASMN1; SMN2NPC1 | |
| SCHEMBL6352408 | 0.78 | NPC1 (0.55) | ALDH1A1KMT2ATSHRLMNASMN1; SMN2 | |
| SCHEMBL6358855 | 0.78 | MAPT (0.57) | POLBALDH1A1KMT2ATSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | POLB 325/4885ALDH1A1 462/4885KMT2A 3645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.